Ming Ni

Title: The Innovative Contributions of Ming Ni

Introduction

Ming Ni is a notable inventor based in Laguna Niguel, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of inflammation. His work has led to the development of innovative methods that have the potential to improve patient outcomes.

Latest Patents

Ming Ni holds a patent titled "Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors." This invention provides a method for treating inflammation in patients by administering an effective amount of a specific compound. The compound's formula includes variations where R is H or lower alkyl, and R1 is hydrocarbyl or substituted hydrocarbyl. The invention emphasizes the use of prodrugs, isomers, and pharmaceutically acceptable salts, showcasing the complexity and potential of his work.

Career Highlights

Ming Ni is associated with Allergan, Inc., a company known for its focus on developing innovative pharmaceuticals. His role at Allergan has allowed him to contribute to groundbreaking research and development in the medical field. His patent reflects his commitment to advancing treatment options for patients suffering from inflammatory conditions.

Collaborations

Ming Ni has collaborated with esteemed colleagues such as Jenny W Wang and David Frederick Woodward. These partnerships have likely enhanced the quality and impact of his research, fostering an environment of innovation and shared expertise.

Conclusion

Ming Ni's contributions to the field of medicine through his patent on inflammation treatment exemplify the importance of innovation in healthcare. His work at Allergan, along with his collaborations, highlights the collaborative nature of scientific advancement. The impact of his inventions may lead to significant improvements in patient care and treatment methodologies.